Tucker Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $9.75K | Buy |
+1,442
| New | +$9.75K | ﹤0.01% | 771 |
|
|
2024
Q2 | – | Sell |
-3,091
| Closed | -$30.8K | – | 1776 |
|
|
2024
Q1 | $30.8K | Buy |
3,091
+3,000
| +3,297% | +$29.9K | 0.01% | 554 |
|
|
2023
Q4 | $897 | Hold |
91
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q3 | $696 | Hold |
91
| – | – | ﹤0.01% | 1227 |
|
|
2023
Q2 | $680 | Hold |
91
| – | – | ﹤0.01% | 1009 |
|
|
2023
Q1 | $607 | Buy |
+91
| New | +$607 | ﹤0.01% | 1036 |
|
|
2022
Q2 | – | Sell |
-30
| Closed | -$215 | – | 693 |
|
|
2022
Q1 | $215 | Buy |
+30
| New | +$215 | ﹤0.01% | 546 |
|